GenePath Dx (@genepathdx) 's Twitter Profile
GenePath Dx

@genepathdx

ID: 4232494245

linkhttp://www.genepathdx.com calendar_today20-11-2015 06:50:12

24 Tweet

105 Followers

22 Following

GenePath Dx (@genepathdx) 's Twitter Profile Photo

One woman dies of cervical cancer every 8 minutes. It is one of the easiest cancers to screen and cure. Smriti Irani Office Devendra Fadnavis #cervicalcancer #HPVDNATesting #cervicalscreening #womenshealth #preventablecancer

GenePath Dx (@genepathdx) 's Twitter Profile Photo

The incidence of cervical cancer in women in India is estimated to be 1.5-2 lakh/year. It is one of the easiest cancers to screen and cure. Smriti Irani Office Devendra Fadnavis #cervicalcancerscreening #HPVDNATesting #WomensHealth #preventablecancer

GenePath Dx (@genepathdx) 's Twitter Profile Photo

Cervical cancer screening coverage in India is less than 10% It is one of the easiest cancers to screen and cure. Smriti Irani Office Smriti Z Irani Devendra Fadnavis Narendra Modi #cervicalcancerscreening #HPVDNATesting #WomensHealth #preventablecancer #smritiirani

GenePath Dx (@genepathdx) 's Twitter Profile Photo

Need help asap in clearing raw material for development of Corona virus test @FedExIndia Vikram Sathaye #COVIDー19 #FedExIndia #coronavirusindia

GenePath Dx (@genepathdx) 's Twitter Profile Photo

Super excited to be the only Indian organization with a regulator (ICMR) approved Covid-19 qRT-PCR test kit and a certified Covid-19 clinical testing lab. A small but dedicated team of 30 people in Pune making an amazing global impact during this pandemic! linkedin.com/posts/nickhilj…

GenePath Dx (@genepathdx) 's Twitter Profile Photo

OurICMR approvd CoviDelta RTPCR kit with Delta/Omicron Marker differentiates betwn current Delta lineage&BOTH Omicron lineage.It reduces d need 2 send all samples dat exhibit S-Gene Target Failure 4 sequencng.Thus kit gives significant savings 4state.Satyendar Jain

GenePath Dx (@genepathdx) 's Twitter Profile Photo

Our 1st ICMR apprvd CoviDelta RTPCR kit with Delta/Omicron Marker differentiates betwn d currently seen Delta & BOTH d emergng Omicron lineages.Kit will reduce need 2 send all samples dat exhibit SGeneTargetFailure 4 sequencing giving significant saving 4 state Arvind Kejriwal

GenePath Dx (@genepathdx) 's Twitter Profile Photo

Just diagnosed what might possibly be India's first #CALR (Calreticulin) mutation in a BCR/ABL -ve Chronic myeloproliferative neoplasm case.

GenePath Dx (@genepathdx) 's Twitter Profile Photo

Providers of Direct-to-Consumer testing in India, too, need to take responsibility and not misguide consumers. x.com/TheACMG/status…

GenePath Dx (@genepathdx) 's Twitter Profile Photo

Great initiative at #ORDIRacefor7. Would encourage as many people to participitate as possible. All the best to the team.

GenePath Dx (@genepathdx) 's Twitter Profile Photo

#GenePathDx found a novel homozygous pathogenic variant in #DGKE gene by inhouse developed NGS assay in an #aHUS patient. #1st in #India.

GenePath Dx (@genepathdx) 's Twitter Profile Photo

GenePath Dx offers 100% accurate duplex testing for Chikungunya and Dengue with same day result. #dengue #chikungunya #pune #fever #bodyache

GenePath Dx (@genepathdx) 's Twitter Profile Photo

Meet Dr. Nikhil Phadke at the 9th edition of the UAE Cancer Congress (UAECC17) on October 5 & 6, 2017 at Dubai uaecancercongress.ae